AbbVie (NYSE:ABBV) Stock Price Expected to Rise, Evercore ISI Analyst Says

AbbVie (NYSE:ABBV – Get Free Report) had its price objective lifted by analysts at Evercore ISI from $204.00 to $205.00 in a report released on Monday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Evercore ISI’s target price suggests a potential upside of 5.92% from the company’s current price. Several other equities […]

Apr 30, 2025 - 08:57

AbbVie (NYSE:ABBV – Get Free Report) had its price objective lifted by analysts at Evercore ISI from $204.00 to $205.00 in a report released on Monday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Evercore ISI’s target price suggests a potential upside of 5.92% from the company’s current price. Several other equities […]